In several HIF-2α-resistant ccRCC cell lines, as well as in HIF-2α-resistant mouse ccRCC models, FTY720 showed anti-proliferative and anti-tumor effects [24]. Here, EPAS1 is linked to nonpapillary renal cell carcinoma.